European journal of clinical investigation · 2026
Pulse Wave Velocity, Mortality and Cardiovascular Disease in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pascual-Morena Carlos, Patiño-Cardona Silvana, Garrido-Miguel Miriam, Martínez-García Irene, Lucerón-Lucas-Torres Maribel, Martínez-Martínez Héctor, Moreno-Charco Elena, Martínez-Hortelano José Alberto
Аннотация
BACKGROUND: Chronic kidney disease (CKD) is associated with high cardiovascular morbidity and mortality, which is mediated by arterial stiffness. Pulse wave velocity (PWV), as measured by the aortic (aPWV), brachial-ankle (baPWV) and carotid-radial (crPWV) indices or estimated by equations (ePWV), could be a powerful predictor of clinical events and mortality in this population. This study aimed to analyse the association between PWV and all-cause mortality, cardiovascular mortality, and cardiovascular disease (CVD) risk in populations with CKD.
METHODS: A systematic search was conducted in PubMed, Scopus, and Web of Science from inception to January 2026. Observational studies estimating the association between PWV, categorically or by an increase of 1 m/s, and the outcomes of interest were included. Random-effects meta-analyses were performed, considering the type of PWV studied. The results are presented as hazard ratios (HR) and their 95% confidence intervals (95% CI).
RESULTS: Twenty-eight studies were included in the systematic review, and 22 in the meta-analyses. Considering a 1 m/s increase in aPWV, HRs of 1.16 (95% CI: 1.06, 1.28), 1.36 (95% CI: 1.15, 1.61), and 1.20 (95% CI: 1.02, 1.41) were found for all-cause mortality, cardiovascular mortality, and CVD risk, respectively. The remaining associations for aPWV, baPWV, and ePWV were categorical and tended to be higher.
CONCLUSIONS: Increased PWV was associated with an increased risk of mortality and CVD. However, given the low quality of the current evidence base, these findings should be interpreted with caution and more rigorous studies are needed to confirm their usefulness in clinical practice.
METHODS: A systematic search was conducted in PubMed, Scopus, and Web of Science from inception to January 2026. Observational studies estimating the association between PWV, categorically or by an increase of 1 m/s, and the outcomes of interest were included. Random-effects meta-analyses were performed, considering the type of PWV studied. The results are presented as hazard ratios (HR) and their 95% confidence intervals (95% CI).
RESULTS: Twenty-eight studies were included in the systematic review, and 22 in the meta-analyses. Considering a 1 m/s increase in aPWV, HRs of 1.16 (95% CI: 1.06, 1.28), 1.36 (95% CI: 1.15, 1.61), and 1.20 (95% CI: 1.02, 1.41) were found for all-cause mortality, cardiovascular mortality, and CVD risk, respectively. The remaining associations for aPWV, baPWV, and ePWV were categorical and tended to be higher.
CONCLUSIONS: Increased PWV was associated with an increased risk of mortality and CVD. However, given the low quality of the current evidence base, these findings should be interpreted with caution and more rigorous studies are needed to confirm their usefulness in clinical practice.